Globesynth Pharma Tech Llp - Company Profile

It is a research & development limited liability partnership based in Salem, Tamil Nadu, India, established in 2019.
2019 Salem, Tamil Nadu, India Active
Last Updated:
About Globesynth Pharma Tech Llp

Globesynth Pharma Tech Llp, a active limited liability partnership, was established on 04 June 2019 in Salem, Tamil Nadu, India. Engaging in research & development within the research & development sector, it holds LLPIN: AAP-5177. Registered under ROC Roc Coimbatore. It has total obligation of contribution of ₹0.30 M.

Its leadership includes Prathima Suryakanth Gudugunti (Designated Partner), Shafi Mohamed Mohamed Rafi (Designated Partner), Bharatkumar Rambhai Patel (Designated Partner). Its latest date of accounts and solvency statement 31 March 2022. It is based at Sf No.147/4 A2, Bangalow Thotam, Uthama Solapuram (Po), Salem, Tamil Nadu, 636010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAP-5177

  • Incorporation Date

    04 June 2019

  • Total Obligation of Contribution

    ₹0.30 M

  • ROC Code

    Roc Coimbatore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.30 M
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2022
Company report

Globesynth Pharma Tech Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Globesynth Pharma Tech Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Globesynth Pharma Tech Llp?
Current Designated Partners
Name Designation Appointment Date Status
Prathima Suryakanth Gudugunti Designated Partner 04 Jun 2019 Current
Shafi Mohamed Mohamed Rafi Designated Partner 04 Jun 2019 Current
Bharatkumar Rambhai Patel Designated Partner 04 Jun 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Globesynth Pharma Tech Llp.

Enhance accessibility to Globesynth Pharma Tech Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Globesynth Pharma Tech Llp revenue growth over time
Globesynth Pharma Tech Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Globesynth Pharma Tech Llp?

Unlock access to Globesynth Pharma Tech Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Globesynth Pharma Tech Llp?

Unlock and access historical data on people associated with Globesynth Pharma Tech Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Globesynth Pharma Tech Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globesynth Pharma Tech Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Globesynth Pharma Tech Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Globesynth Pharma Tech Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Globesynth Pharma Tech Llp has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Coimbatore. was completed.

  • Director Appointment

    The activity Prathima Suryakanth Gudugunti was appointed as a Designated Partner was appointed as a Designated Partner on 04 Jun 2019 & has been associated with this company since 6 years 8 months . was completed.

  • Director Appointment

    Shafi Mohamed Mohamed Rafi was appointed as a Designated Partner was appointed as a Designated Partner on 04 Jun 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Bharatkumar Rambhai Patel was appointed as a Designated Partner was appointed as a Designated Partner on 04 Jun 2019 & has been associated with this company since 6 years 8 months . was completed.

  • LLP Incorporation

    Progress on Globesynth Pharma Tech Llp was registered on 04 Jun 2019 with Roc Coimbatore & aged 6 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Globesynth Pharma Tech Llp?

The LLPIN of Globesynth Pharma Tech Llp is AAP-5177.

Where is Globesynth Pharma Tech Llp headquartered?

Globesynth Pharma Tech Llp is headquartered at Sf No.147/4 A2, Bangalow Thotam, Uthama Solapuram (Po), Salem, Tamil Nadu, 636010.

When was Globesynth Pharma Tech Llp incorporated?

Globesynth Pharma Tech Llp was incorporated on 04 June 2019.

Who are the current directors of Globesynth Pharma Tech Llp?

The current directors of Globesynth Pharma Tech Llp are

What is the primary industry of Globesynth Pharma Tech Llp?

The primary industry of Globesynth Pharma Tech Llp is Research & Development.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available